Long XR - Search Results

1

Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.

Wang RQ, Long XR, Ge CL, Zhang MY, Huang L, Zhou NN, Hu Y, Li RL, Li Z, Chen DN, Zhang LJ, Wen ZS, Mai SJ, Wang HY. Wang RQ, et al. Among authors: long xr. J Transl Med. 2020 Aug 20;18(1):320. doi: 10.1186/s12967-020-02485-8. J Transl Med. 2020. PMID: 32819367 Free PMC article.

2

MicroRNA-711 is a prognostic factor for poor overall survival and has an oncogenic role in breast cancer.

Hu JY, Yi W, Zhang MY, Xu R, Zeng LS, Long XR, Zhou XM, Zheng XS, Kang Y, Wang HY. Hu JY, et al. Among authors: long xr. Oncol Lett. 2016 Mar;11(3):2155-2163. doi: 10.3892/ol.2016.4217. Epub 2016 Feb 9. Oncol Lett. 2016. PMID: 26998141 Free PMC article.

3

Identification of an 88-microRNA signature in whole blood for diagnosis of hepatocellular carcinoma and other chronic liver diseases.

Long XR, Zhang YJ, Zhang MY, Chen K, Zheng XFS, Wang HY. Long XR, et al. Aging (Albany NY). 2017 Jun 27;9(6):1565-1584. doi: 10.18632/aging.101253. Aging (Albany NY). 2017. PMID: 28657540 Free PMC article.

4

Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer.

Wang RQ, Long XR, Zhou NN, Chen DN, Zhang MY, Wen ZS, Zhang LJ, He FZ, Zhou ZL, Mai SJ, Wang HY. Wang RQ, et al. Among authors: long xr. J Exp Clin Cancer Res. 2021 Jan 6;40(1):9. doi: 10.1186/s13046-020-01819-0. J Exp Clin Cancer Res. 2021. PMID: 33407724 Free PMC article.

5

LncRNA GAS5 suppresses ovarian cancer progression by targeting the miR-96-5p/PTEN axis.

Dong Q, Long X, Cheng J, Wang W, Tian Q, Di W. Dong Q, et al. Ann Transl Med. 2021 Dec;9(24):1770. doi: 10.21037/atm-21-6134. Ann Transl Med. 2021. PMID: 35071464 Free PMC article.

6

Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.

Long X, Song K, Hu H, Tian Q, Wang W, Dong Q, Yin X, Di W. Long X, et al. J Exp Clin Cancer Res. 2019 Aug 7;38(1):345. doi: 10.1186/s13046-019-1329-2. J Exp Clin Cancer Res. 2019. PMID: 31391118 Free PMC article.

7

Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma.

Liu X, Lu H, Zhou Y, Long X, Li Q, Zhuang G, Yin X, Di W. Liu X, et al. Cancer Med. 2023 May;12(10):11385-11395. doi: 10.1002/cam4.5853. Epub 2023 Mar 27. Cancer Med. 2023. PMID: 36971044 Free PMC article.

8

APOBEC3B stratifies ovarian clear cell carcinoma with distinct immunophenotype and prognosis.

Long X, Lu H, Cai MC, Zang J, Zhang Z, Wu J, Liu X, Cheng L, Cheng J, Cheung LWT, Shen Z, Zhou Y, Di W, Zhuang G, Yin X. Long X, et al. Br J Cancer. 2023 Jun;128(11):2054-2062. doi: 10.1038/s41416-023-02239-5. Epub 2023 Mar 30. Br J Cancer. 2023. PMID: 36997661 Free PMC article.

9

Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase.

Song K, Dai L, Long X, Wang W, Di W. Song K, et al. Sci Rep. 2020 Aug 14;10(1):13834. doi: 10.1038/s41598-020-70896-0. Sci Rep. 2020. PMID: 32796926 Free PMC article.

10

Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo.

Song K, Dai L, Long X, Cui X, Liu Y, Di W. Song K, et al. Onco Targets Ther. 2019 Jun 6;12:4437-4449. doi: 10.2147/OTT.S208519. eCollection 2019. Onco Targets Ther. 2019. PMID: 31239712 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters